Events, Appointments, Joint Ventures, and Acquisitions - Research Report on Merrimack, Opko Health, Hill-Rom, LifePoint, and Kindred Healthcare

NEW YORK, December 9, 2013 /PRNewswire/ --


Today, Analysts' Corner announced new research reports highlighting Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), Opko Health, Inc. (NYSE: OPK), Hill-Rom Holdings, Inc. (NYSE: HRC), LifePoint Hospitals Inc. (NASDAQ: LPNT), and Kindred Healthcare Inc. (NYSE: KND). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Merrimack Pharmaceuticals, Inc. Research Report

On December 4, 2013, Merrimack Pharmaceuticals, Inc. (Merrimack) announced that it will present during the upcoming Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11, 2013 at 8:55 a.m. ET. Merrimack reported that the event will be held at the Crowne Plaza Hotel in New York. The Company noted that the live webcast and replay of the presentation will be accessible through the Investors section on its website for 2 weeks. The Full Research Report on Merrimack Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/8bb0_MACK

--

Opko Health, Inc. Research Report

On December 4, 2013, Opko Health, Inc. (Opko Health) announced that it will present during the upcoming Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10, 2013 at 10:55 a.m. ET. According to Opko Health, its senior management will provide a review of recent corporate developments. The Company reported that the presentation will be webcast live, while an archived version of the audio presentation will be available on the Investor Relations section of its corporate website for a limited time. The Full Research Report on Opko Health, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/cd43_OPK

--

Hill-Rom Holdings, Inc. Research Report

On December 2, 2013, Hill-Rom Holdings, Inc. (Hill-Rom) announced the appointment of James "Jay" Saccaro as Senior Vice President and Chief Financial Officer. Hill-Rom reported that Saccaro will assume the positions on December 30, 2013. John Greisch, President and CEO of Hill-Rom, commented, "Jay brings to Hill-Rom a proven record of delivering strong financial and operating results and extensive experience leading global health care teams." Greisch added, "He is an outstanding addition to our leadership team as we continue to pursue our growth strategy and deliver increased value for our shareholders. We are delighted to have him on board." The Full Research Report on Hill-Rom Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/777e_HRC

--

LifePoint Hospitals Inc. Research Report

On December 2, 2013, LifePoint Hospitals Inc. (LifePoint) announced that the Company and Portage Health's Board of Directors have finalized a joint venture agreement to share ownership and operation of Portage Health. According to LifePoint, the joint venture will bring $60 million in capital improvements to Portage Health and approximately $40 million to fund a charitable foundation to support critical needs in the community. William F. Carpenter III, Chairman and CEO of LifePoint, stated, "Portage Health plays an important role in healthcare in the Upper Peninsula, and LifePoint is delighted to be its partner." Carpenter continued, "We look forward to working with Portage Health's leadership, physicians, employees and volunteers as we continue to find new ways to enhance healthcare delivery in Hancock-Houghton and throughout the Copper Country region." The Full Research Report on LifePoint Hospitals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/f06d_LPNT

--

Kindred Healthcare Inc. Research Report

On December 2, 2013, Kindred Healthcare Inc. (Kindred) announced that it has successfully completed its acquisition of Senior Home Care, Inc. (Senior Home Care) for a total consideration of $95 million. Kindred reported that the transaction was financed with operating cash flows and proceeds from its revolving credit facility. The Company expects the Senior Home Care acquisition to be accretive in its 2014 earnings. Paul J. Diaz, Kindred's CEO, said, "Expanding our Care Management capabilities, particularly within our Integrated Care Markets, allows Kindred to improve care coordination throughout an episode of care, improving outcomes and each patient's experience, as we work to support well-being and independence at home." The Full Research Report on Kindred Healthcare Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/ab58_KND

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts' Corner

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.